Bioimplants Market Growth Powered with Latest Development Scenario and Influencing Trends 2017-2023

A Comprehensive research study conducted by KD Market Research on  Bioimplants Market Opportunity Analysis and Industry forecast. report offers extensive and highly detailed historical, current and future market trends in Bioimplants Market . Bioimplants Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.

Bioimplant are medical devices or tissues that are surgically transplanted inside the body. These implants are used to replace or support any damaged body organs to enhance function of any body organ or to detect errors in normal body functioning. These can be either placed permanently or temporarily in human body and can be removed when they are no longer needed. Some of the implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other materials.

Request sample Copy of this Report@ https://www.kdmarketresearch.com/sample/3221

The global bioimplant market was evaluated at $77,738 million in 2016, and is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% during the forecast period. The growth in the bioimplant market is primarily attributed to the rise in prevalence of chronic diseases coupled with the rapidly aging population. Moreover, increased awareness and technological advancements in bioimplant further support the growth of the market. However, high implantation cost and lack of expertise are some of the factors that restrain the growth of the bioimplant market.

The global bioimplant market is segmented based on product type, material, and region. Based on product type, the market is categorized into cardiovascular implant, dental implant, orthopedic implant, spinal implant, ophthalmic implant, and others. By material type, it is divided into metallic biomaterial, ceramic biomaterial, polymer biomaterial, and natural biomaterials. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

-This report provides an extensive analysis of the current and emerging trends and dynamics in the global bioimplants market to identify the prevailing opportunities.

-It presents a competitive landscape of the global market to predict the competitive environment across geographies.

-Comprehensive analysis of factors that drive and restrict the market growth is provided.

-Region- and country-wise analyses are provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Type

-Cardiovascular bioimplant
-Stent
-Coronary stent
-Drug-eluting stent (DES)
-Bare-metal coronary stent
-Bioabsorbable stent
-Peripheral stent
-Iliac
-Femoral-popliteal
-Renal
-Carotid
-Stent-related bioimplant
-Synthetic graft
-Vena Cava filter
-Pacing device
-Cardiac resynchronization therapy device (CRTs)
-Implantable cardioverter defibrillator (ICDs)
-Implantable cardiac pacemaker (ICPs)
-Structural Cardiac Implant
-Mechanical heart valve
-Implantable ventricular-assist device
-Dental bioimplant
-Plate form dental implant
-Root form dental implant
-Orthopedic bioimplant
-Reconstructive joint replacement
-Knee replacement implant
-Hip replacement implant
-Extremities
-Orthobiologics
-Trauma & craniomaxillofacial
-Spinal bioimplant
-Spinal fusion implant
-Spinal bone stimulator
-Vertebral compression fracture (VCF) device
-Motion preservation devices/non-fusion device
-Spine biologics
-Ophthalmology bioimplant
-Glaucoma implant
-Intraocular implant
-Others

By material

-Metallic biomaterial
-Ceramic biomaterial
-Polymers biomaterial
-Natural biomaterial

By Region

-North America
-U.S.
-Canada
-Mexico
-Europe
-Germany
-France
-UK
-Italy
-Spain
-Rest of Europe
-Asia-Pacific
-Japan
-China
-India
-Australia
-Rest of Asia-Pacific
-LAMEA
-Brazil
-Saudi Arabia
-South Africa
-Rest of LAMEA

The key players profiled in this report are as follows:

-Abbott Laboratories (St. Jude Medical, Inc.)
-Boston Scientific Corporation
-Dentsply Sirona Inc.
-Johnson & Johnson (Ethicon, Inc.)
-Medtronic plc
-Smith & Nephew plc
-Stryker Corporation
-Victrex Plc. (Invibio Ltd.)
-Wright Medical Group N.V.
-Zimmer Biomet Holdings Inc.

The other players in the value chain include (*These players have not been profiled in the report, but can be included on request.):

-GC Aesthetics plc
-Allergan Inc.
-Sientra Inc.
-Danaher Corporation
-3M Company
-Polytech Health & Aesthetics GmbH
-B. Braun Melsungen AG
-Elixir Medical Corporation
-Microport Scientific Corporation
-STENTYS S.A.
-Terumo Corporation

Browse Complete Research Report with toc@ https://www.kdmarketresearch.com/report/3221/bioimplants-market-amr

Table of Content

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Top player positioning, 2016
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Growth in elderly population and rise in prevalence of chronic diseases
3.4.1.2. Technological advancements in the field of bioimplant
3.4.1.3. Global rise in acceptance of bioimplant
3.4.1.4. Better insurance and reimbursement
3.4.1.5. Increase in government focus on funding R&D initiatives

3.4.2. Restraints

3.4.2.1. High cost of treatment associated with bioimplant
3.4.2.2. Stringent approval process

3.4.3. Opportunities

3.4.3.1. Huge market opportunities in the APAC region and developing countries
3.4.3.2. Increase in development of minimally invasive and non-surgical procedures
3.4.3.3. Rise in awareness amongst patients and increasing preference for a better quality of life

3.4.4. Impact analysis

CHAPTER 4: BIOIMPLANT MARKET BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Cardiovascular implant

4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by type
4.2.3. Stent

4.2.3.1. Market size and forecast
4.2.3.2. Coronary stent

4.2.3.2.1. Market size and forecast
4.2.3.2.2. Drug-eluting stent

4.2.3.2.2.1. Market size and forecast

4.2.3.2.3. Bare-metal coronary stent

4.2.3.2.3.1. Market size and forecast

4.2.3.2.4. Bioabsorbable stent

4.2.3.2.4.1. Market size and forecast

4.2.3.3. Peripheral stent

4.2.3.3.1. Market size and forecast
4.2.3.3.2. Iliac stent

4.2.3.3.2.1. Market size and forecast

4.2.3.3.3. Femoral-popliteal stent

4.2.3.3.3.1. Market size and forecast

4.2.3.3.4. Renal stent

4.2.3.3.4.1. Market size and forecast

4.2.3.3.5. Carotid stent

4.2.3.3.5.1. Market size and forecast

4.2.3.4. Stent-related implant

4.2.3.4.1. Market size and forecast
4.2.3.4.2. Synthetic graft

4.2.3.4.2.1. Market size and forecast

4.2.3.4.3. Vena cava filter

4.2.3.4.3.1. Market size and forecast

4.2.4. Pacing device

4.2.4.1. Market size and forecast
4.2.4.2. Cardiac resynchronisation therapy (CRT)

4.2.4.2.1. Market size and forecast

4.2.4.3. Implantable cardioverter defibrillators (ICDs)

4.2.4.3.1. Market size and forecast

4.2.4.4. Implantable cardiac pacemaker (ICP)

4.2.4.4.1. Market size and forecast

4.2.5. Structural cardiac implant

4.2.5.1. Market size and forecast
4.2.5.2. Mechanical heart valve

4.2.5.2.1. Market size and forecast

4.2.5.3. Implantable ventricular-assist device (VAD)

4.2.5.3.1. Market size and forecast

4.2.6. Market size and forecast, by region
4.2.7. Market analysis, by country

4.3. Dental and prosthetic implant

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type

4.3.2.1. Plate form dental implants

4.3.2.1.1. Market size and forecast

4.3.2.2. Root form dental implants

4.3.2.2.1. Market size and forecast

4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country

4.4. Orthopedic implant

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type

4.4.2.1. Reconstructive joint replacements

4.4.2.1.1. Market size and forecast
4.4.2.1.2. Knee replacement implants

4.4.2.1.2.1. Market size and forecast

4.4.2.1.3. Hip replacement implants

4.4.2.1.3.1. Market size and forecast

4.4.2.1.4. Extremities

4.4.2.1.4.1. Market size and forecast

4.4.2.2. Orthobiologics

4.4.2.2.1. Market size and forecast

4.4.2.3. Trauma & craniomaxillofacial

4.4.2.3.1. Market size and forecast

4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country

4.5. Ophthalmic implants

4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by type

4.5.2.1. Intraocular lens

4.5.2.1.1. Market size and forecast

4.5.2.2. Glaucoma implant

4.5.2.2.1. Market size and forecast

4.5.3. Market size and forecast, by region
4.5.4. Market analysis, by country

4.6. Spinal implants

4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by type

4.6.2.1. Spinal fusion devices

4.6.2.1.1. Market size and forecast

4.6.2.2. Motion preservation device

4.6.2.2.1. Market size and forecast

4.6.2.3. Vertebral compression fracture (VCF) devices

4.6.2.3.1. Market size and forecast

4.6.2.4. Spinal bone stimulators

4.6.2.4.1. Market size and forecast

4.6.2.5. Spine biologics

4.6.2.5.1. Market size and forecast

4.6.3. Market size and forecast, by region
4.6.4. Market analysis, by country

4.7. Other implants

4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country

CHAPTER 5: BIOIMPLANT MARKET, BY MATERIAL

5.1. Overview

5.1.1. Market size and forecast

5.2. Metallic Biomaterials

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Ceramic Biomaterial

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Polymer Biomaterial

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Natural Biomaterials

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

CHAPTER 6: BIOIMPLANT MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America market size and forecast, by country

6.2.2.1. U.S. bioimplant market size and forecast

6.2.2.1.1. U.S. bioimplant market size and forecast, by product
6.2.2.1.2. U.S. bioimplant market size and forecast, by material

6.2.2.2. Canada bioimplant market size and forecast

6.2.2.2.1. Canada bioimplant market size and forecast, by product
6.2.2.2.2. Canada bioimplant market size and forecast, by material

6.2.2.3. Mexico bioimplant market size and forecast

6.2.2.3.1. Mexico bioimplant market size and forecast, by product
6.2.2.3.2. Mexico bioimplant market size and forecast, by material

6.2.3. North America market size and forecast, by product
6.2.4. North America market size and forecast, by material

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe market size and forecast, by country

6.3.2.1. Germany bioimplant market size and forecast

6.3.2.1.1. Germany bioimplant market size and forecast, by product
6.3.2.1.2. Germany bioimplant market size and forecast, by material

6.3.2.2. France bioimplant market size and forecast

6.3.2.2.1. France bioimplant market size and forecast, by product
6.3.2.2.2. France bioimplant market size and forecast, by material

6.3.2.3. UK bioimplant market size and forecast

6.3.2.3.1. UK bioimplant market size and forecast, by product
6.3.2.3.2. UK bioimplant market size and forecast, by material

6.3.2.4. Italy bioimplant market size and forecast

6.3.2.4.1. Italy bioimplant market size and forecast, by product
6.3.2.4.2. Italy bioimplant market size and forecast, by material

6.3.2.5. Spain bioimplant market size and forecast

6.3.2.5.1. Spain bioimplant market size and forecast, by product
6.3.2.5.2. Spain bioimplant market size and forecast, by material

6.3.2.6. Rest of Europe bioimplant market size and forecast

6.3.2.6.1. Rest of Europe bioimplant market size and forecast, by product
6.3.2.6.2. Rest of Europe bioimplant market size and forecast, by material

6.3.3. Europe market size and forecast, by product
6.3.4. Europe market size and forecast, by material

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific market size and forecast, by country

6.4.2.1. Japan bioimplant market size and forecast

6.4.2.1.1. Japan bioimplant market size and forecast, by product
6.4.2.1.2. Japan bioimplant market size and forecast, by material

6.4.2.2. China bioimplant market size and forecast

6.4.2.2.1. China bioimplant market size and forecast, by product
6.4.2.2.2. China bioimplant market size and forecast, by material

6.4.2.3. India bioimplant market size and forecast

6.4.2.3.1. India bioimplant market size and forecast, by product
6.4.2.3.2. India bioimplant market size and forecast, by material

6.4.2.4. Australia bioimplant market size and forecast

6.4.2.4.1. Australia bioimplant market size and forecast, by product
6.4.2.4.2. Australia bioimplant market size and forecast, by material

6.4.2.5. Rest of Asia-Pacific bioimplant market size and forecast

6.4.2.5.1. Rest of Asia-Pacific bioimplant market size and forecast, by product
6.4.2.5.2. Rest of Asia-Pacific bioimplant market size and forecast, by material

6.4.3. Asia-Pacific market size and forecast, by product
6.4.4. Asia-Pacific market size and forecast, by material

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA market size and forecast, by country

6.5.2.1. Brazil bioimplant market size and forecast

6.5.2.1.1. Brazil bioimplant market size and forecast, by product
6.5.2.1.2. Brazil bioimplant market size and forecast, by material

6.5.2.2. South Africa bioimplant market size and forecast

6.5.2.2.1. South Africa bioimplant market size and forecast, by product
6.5.2.2.2. South Africa bioimplant market size and forecast, by material

6.5.2.3. Saudi Arabia bioimplant market size and forecast

6.5.2.3.1. Saudi Arabia bioimplant market size and forecast, by product
6.5.2.3.2. Saudi Arabia bioimplant market size and forecast, by material

6.5.2.4. Rest of LAMEA bioimplant market size and forecast

6.5.2.4.1. Rest of LAMEA bioimplant market size and forecast, by product
6.5.2.4.2. Rest of LAMEA bioimplant market size and forecast, by material

6.5.3. LAMEA market size and forecast, by product
6.5.4. LAMEA market size and forecast, by material

CHAPTER 7: COMPANY PROFILES

7.1. Abbott Laboratories (St. Jude Medical, Inc.)

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. Boston Scientific Corporation

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. Dentsply Sirona Inc.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. Johnson & Johnson (Ethicon, Inc.)

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. Medtronic plc

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. Smith & Nephew plc

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. Stryker Corporation

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. Victrex Plc. (Invibio Ltd.)

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. Wright Medical Group N.V.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance

7.10. Zimmer Biomet Holdings Inc.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

Request for Exclusive Discount @ https://www.kdmarketresearch.com/discount/3221

About Us:

KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.

Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.

Contact us -

KD Market Research

150 State Street, Albany,

New York, USA 12207

Website: www.kdmarketresearch.com

Email id-  sales@kdmarketresearch.com

More - https://kdmarketresearch.blogspot.com/